IL6 and diabetes mellitus: Studies have shown that the increased release of inflammatory factors (such as TNF-α, IL-6, C-reactive protein) and the decreased release of anti-inflammatory cytokines (such as IL-10) can lead to the increased activation of adipose tissue, increased insulin resistance, and further progression to diabetes [31,32].